Authors:
Loetchutinat, C
Heywang, C
Priebe, W
Garnier-Suillerot, A
Citation: C. Loetchutinat et al., The absence of stereoselective P-glycoprotein- and multidrug resistance-associated protein-mediated transport of daunorubicin, BIOCH PHARM, 62(5), 2001, pp. 561-567
Authors:
Mishra, M
Porter-Kelley, JM
Singh, PK
Bennett, JR
Chaudhuri, G
Citation: M. Mishra et al., Enhanced activity of antisense phosphorothioate oligos against Leishmania amastigotes: augmented uptake of oligo, ribonuclease H activation, and efficient target intervention under altered growth conditions, BIOCH PHARM, 62(5), 2001, pp. 569-580
Authors:
Berry, A
Goodwin, M
Moran, CL
Chambers, TC
Citation: A. Berry et al., AP-1 activation and altered AP-1 composition in association with increasedphosphorylation and expression of specific Jun and Fos family proteins induced by vinblastine in KB-3 cells, BIOCH PHARM, 62(5), 2001, pp. 581-591
Authors:
Magnet, KJ
Orr, MS
Cleveland, JL
Rodriguez-Galindo, C
Yang, H
Yang, CY
Di, YM
Jain, PT
Gewirtz, DA
Citation: Kj. Magnet et al., Suppression of c-myc expression and c-Myc function in response to sustained DNA damage in MCF-7 breast tumor cells, BIOCH PHARM, 62(5), 2001, pp. 593-602
Citation: Y. Habraken et al., S phase dependence and involvement of NF-kappaB activating kinase to NF-kappaB activation by camptothecin, BIOCH PHARM, 62(5), 2001, pp. 603-616
Citation: Mm. Iba et J. Fung, Pulmonary CYP1A1 and CYP1A2 levels and activities in adult male and femaleoffspring of rats exposed during gestation and lactation to 2,3,7,8-tetrachlorodibenzo-p-dioxin, BIOCH PHARM, 62(5), 2001, pp. 617-626
Authors:
Bijsterbosch, MK
Manoharan, M
Dorland, R
Waarlo, IHE
Biessen, EAL
van Berkel, TJC
Citation: Mk. Bijsterbosch et al., Delivery of cholesteryl-conjugated phosphorothioate oligodeoxynucleotides to Kupffer cells by lactosylated low-density lipoprotein, BIOCH PHARM, 62(5), 2001, pp. 627-633
Authors:
Sivapathasundaram, S
Magnisali, P
Coldham, NG
Howells, LC
Sauer, MJ
Ioannides, C
Citation: S. Sivapathasundaram et al., A study of the expression of the xenobiotic-metabolising cytochrome P450 proteins and of testosterone metabolism in bovine liver, BIOCH PHARM, 62(5), 2001, pp. 635-645
Citation: Eh. Oliw et al., Oxidation of prostaglandin H-2 and prostaglandin H-2 analogues by human cytochromes P450: analysis of omega-side chain hydroxy metabolites and four steroisomers of 5-hydroxyprostaglandin I-1 by mass spectrometry, BIOCH PHARM, 62(4), 2001, pp. 407-415
Citation: Kv. Cullen et al., Verapamil-stimulated glutathione transport by the multidrug resistance-associated protein (MRP1) in leukaemia cells, BIOCH PHARM, 62(4), 2001, pp. 417-424
Authors:
Boadu, E
Vaskinn, S
Sundkvist, E
Jaeger, R
Sager, G
Citation: E. Boadu et al., Inhibition by guanosine cyclic monophosphate (cGMP) analogues of uptake of[H-3]3',5'-cGMP without stimulation of ATPase activity in human erythrocyte inside-out vesicles, BIOCH PHARM, 62(4), 2001, pp. 425-429
Citation: Rhp. Porter et al., Agonist-induced functional desensitization of recombinant human 5-HT2 receptors expressed in CHO-K1 cells, BIOCH PHARM, 62(4), 2001, pp. 431-438
Authors:
Fulgencio, JP
Kohl, C
Girard, J
Pegorier, JP
Citation: Jp. Fulgencio et al., Effect of metformin on fatty acid and glucose metabolism in freshly isolated hepatocytes and on specific gene expression in cultured hepatocytes, BIOCH PHARM, 62(4), 2001, pp. 439-446
Authors:
Selley, DE
Cao, CC
Sexton, T
Schwegel, JA
Martin, TJ
Childers, SR
Citation: De. Selley et al., mu Opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetylmorphine compared with morphine, BIOCH PHARM, 62(4), 2001, pp. 447-455
Citation: Ae. Cribb et al., Effect of lipopolysaccharide (LPS)-evoked host defense activation on hepatic microsomal formation and reduction of sulfamethoxazole hydroxylamine in the rat, BIOCH PHARM, 62(4), 2001, pp. 457-459
Authors:
Bailey, SM
Lewis, AD
Patterson, LH
Fisher, GR
Knox, RJ
Workman, P
Citation: Sm. Bailey et al., Involvement of NADPH: cytochrome P450 reductase in the activation of indoloquinone EO9 to free radical and DNA damaging species, BIOCH PHARM, 62(4), 2001, pp. 461-468
Authors:
Smith, JA
Madden, T
Vijjeswarapu, M
Newman, RA
Citation: Ja. Smith et al., Inhibition of export of fibroblast growth factor-2 (FGF-2) from the prostate cancer cell lines PC3 and DU145 by Anvirzel and its cardiac glycoside component, oleandrin, BIOCH PHARM, 62(4), 2001, pp. 469-472
Citation: Kkw. Au-yeung et al., Inhibition of stress-activated protein kinase in the ischemic/reperfused heart: role of magnesium tanshinoate B in preventing apoptosis, BIOCH PHARM, 62(4), 2001, pp. 483-493
Citation: N. Kanda et S. Watanabe, Regulatory roles of adenylate cyclase and cyclic nucleotide phosphodiesterases 1 and 4 in interleukin-13 production by activated human T cells, BIOCH PHARM, 62(4), 2001, pp. 495-507
Authors:
Elimadi, A
Sapena, R
Settaf, A
Le Louet, H
Tillement, JP
Morin, D
Citation: A. Elimadi et al., Attenuation of liver normothermic ischemia-reperfusion injury by preservation of mitochondrial functions with S-15176, a potent trimetazidine derivative, BIOCH PHARM, 62(4), 2001, pp. 509-516
Authors:
Achard, JM
Fournier, A
Mazouz, H
Caride, VJ
Penar, PL
Fernandez, LA
Citation: Jm. Achard et al., Protection against ischemia: a physiological function of the renin-angiotensin system, BIOCH PHARM, 62(3), 2001, pp. 261-271
Citation: Tp. Twaroski et al., Effects of selected polychlorinated biphenyl (PCB) congeners on hepatic glutathione, glutathione-related enzymes, and selenium status: implications for oxidative stress, BIOCH PHARM, 62(3), 2001, pp. 273-281
Authors:
Grant, ER
Errico, MA
Emanuel, SL
Benjamin, D
McMillian, MK
Wadsworth, SA
Zivin, RA
Zhong, Z
Citation: Er. Grant et al., Protection against glutamate toxicity through inhibition of the p44/42 mitogen-activated protein kinase pathway in neuronally differentiated P19 cells, BIOCH PHARM, 62(3), 2001, pp. 283-296